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The retinoid-related orphan receptor α (RORα) belongs to the nuclear receptor superfamily and comprises four isoforms generated by different
promotor usage and alternative splicing. To better understand its function, the subcellular distribution of RORα was investigated. We could show
that subcellular distribution of RORα is cell line and isoform-dependent. Isoform specific differences were mediated by the A/B domains which
with the exception of RORα1 contain a signal that mediates cytoplasmic localization. The lack of this signal in RORα1 results in a complete
nuclear localization and prevents cell membrane association observed for RORα2, 3, and 4. The region responsible for membrane association was
identified as the C-terminal α-helix 12. Furthermore, the hinge region/ligand binding domain mediates nuclear localization. Our results show that
isoform specific activity of RORα is not only regulated by different expression and DNA binding affinities but also by different subcellular
distribution. Different access to the nucleus reveals an important mechanism regulating the activity of this constitutively active nuclear receptor.
© 2006 Elsevier B.V. All rights reserved.Keywords: RORα; Cholesterol; 293 HEK cell; HeLa cell; Cellular distribution; Nuclear receptor1. Introduction
The retinoid-related orphan receptor α (RORα) belongs to the
superfamily of nuclear receptors consisting of structurally related,
ligand-dependent transcription factors, which control numerous
processes involved in the maintenance of homeostasis, in
development, growth, cell differentiation, proliferation, and
apoptosis [1]. They transduce extracellular hormone signals via
binding to specific cis-acting DNA sequences in the promoter
region of target genes, known as response elements. Besides
receptors for ligands such as glucocorticoids, estrogens, thyroid
hormone, retinoic acid, and vitaminD, a large number of so-called
orphan receptors with so far unknown ligands have been iden-
tified based on domain organization and sequence conservation
[2,3]. All nuclear receptors share a common modular structure
with several independent functional domains [4,5]. The veryAbbreviations: CLSM, confocal laser scan microscopy; DBD, DNA binding
domain; EGFP, enhanced green fluorescent protein; LBD, ligand binding
domain; NES, nuclear export signal; NLS, nuclear localization signal; NR,
nuclear receptor; ROR, retinoid-related orphan receptor; RORE, RORα
response element
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doi:10.1016/j.bbamcr.2006.05.006variable N-terminal A/B domain is followed by the highly
conserved DNA binding domain (DBD) which encompasses two
zinc fingermotifs, a flexible hinge region, and a C-terminal ligand
binding domain (LBD). The transcriptional activity of nuclear
receptors can be regulated by ligand binding, by the regulation of
their gene expression [6], by posttranscriptional mechanisms
including phosphorylation [7,8], acetylation and ubiquitinylation
as well as by the modulation of their intracellular localization [9].
The subcellular distribution of nuclear receptors is the result of
a dynamic and controlled shuttling between cytosol and nucleus
as demonstrated for the progesterone receptor [10]. Balancing
nuclear import and export can be an important mechanism to
regulate the transactivation potential of nuclear receptors,
especially in the case of constitutively active receptors. Depend-
ing on their intracellular localization, nuclear receptors can be
divided into three categories: (I) exclusively cytoplasmic recep-
tors like the glucocorticoid receptor [11], (II) both cytoplasmic
and nuclear like the mineralocorticoid receptor [12], and (III)
exclusively nuclear like the progesterone receptor [13,14]. Active
translocation of a cytoplasmic receptor into the nucleus is mostly
mediated by ligand binding [15–18]. It depends on nuclear
localization signals (NLS), typically short sequences rich in basic
amino acids [18]. It is believed that ligand binding induces
Table 1
Oligonucleotide pairs and amplification conditions used for RT-PCR analysis
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which subsequently becomes accessible to nuclear import factors
that facilitate translocation through the nuclear pore complex [19].
Certain nuclear receptors have also been shown to undergo export
from the nucleus. A nuclear export signal present in the DNA
binding domain of diverse receptors has been identifiedwithin the
glucocorticoid receptor [20]. Furthermore, membrane-associated
forms of several nuclear receptors have been described [21–24]. It
is supposed that these membrane-associated receptors mediate
rapid, non-genomic effects of steroids such as stimulation of
signaling cascades via modulation of kinase activities and regu-
lation of second messengers including cAMP.
The retinoid-related orphan receptor subfamily of nuclear
receptors consists of the three ROR subtypesα,β, and γ (NR1F1,
NR1F2 and NR1F3 [25]) which are encoded by different genes.
The ROR subtype α is believed to be a constitutive activator of
transcription in the absence of exogenous ligands [26]. Recently,
cholesterol was found in the ligand binding pocket of the crys-
tallized ligand binding domain suggesting that it might be a
natural ligand of RORα [27]. By now, four human isoforms of
RORα were identified [28,29]. These isoforms are a result of
different promoter usage and alternative splicing and differ only in
their N-terminal domains, resulting in different DNA binding
properties [28]. They show different tissue distribution with
RORα1 and RORα4 expressed more ubiquitously [29,30], while
RORα2 and RORα3 are expressed in a more restricted manner.
RORα3 was only found in human testis [31], RORα2 could be
detected in human testis as well as in cells of the immune system
[31,32]. The precise role of RORα in various tissues still remains
to be elucidated. However, it has been shown that RORα neg-
atively regulates inflammatory responses [33]. Homozygous
RORα-deficient mice as well as the so-called staggerer mice that
express a RORα truncation mutant, show a severe cerebellar
ataxia phenotype [31,34–36], abnormalities in social and sexual
behavior, and an increased risk in developing atherosclerosis [37]
and osteoporosis [38,39]. Furthermore, RORα together with Rev-
erbα was recently found to be essentially involved in the main-
tenance of the circadian rhythm [40].
In this study, we investigated the cell type- and isoform-
specific intracellular localization of RORα. We decided to use
green fluorescent protein chimeras to analyze intracellular local-
ization since GFPwas shown towork as a functional tag for many
nuclear receptors [11,12,14,16–18,20]. We demonstrate that the
A/B domains of RORα2, 3 and 4 but not that of RORα1 confer a
cytoplasmic localization suggesting either nuclear export or
cytoplasmic retention and that the common part of the four
isoforms mediates nuclear localization. Furthermore, the role of
the C-terminal part of RORα, containing helix 12, for the ob-
served membrane localization was elucidated.
2. Materials and methods
2.1. Cell culture
293 HEK, HeLa, MCF-7, and SH-SY5Y cells were cultured as monolayers in
DMEM (Invitrogen). Medium was supplemented with 10% FCS, 100 μg/ml
streptomycin and 100 U/ml penicillin. If indicated, charcoal-stripped FCS was
used.2.2. RT-PCR analysis
Extraction of total RNA from cultured cell lines was performed according to
the method of Chomczynski and Sacchi [41]. β-mercaptoethanol was added to a
final concentration of 2%. Putative genomic DNAwas digested with DNase at
37 °C for 1 h. The enzyme was removed by chloroform–phenol extraction.
Reverse transcription was performed with Superscript Plus reverse transcrip-
tase (Invitrogen) according to manufacturer's instructions using oligo-d(T)12–18
primer. PCR primer pairs and conditions for touch down PCR are listed in Table 1.
2.3. Construction of EGFP chimeras
pEGFP-N1 and pEGFP-C2 (Clontech)were chosen for cloning and expression.
Expression vectors for RORα isoforms pCMX-RORα1, pCMX-RORα2, pCMX-
RORα3, and pSG5-RORα4 were kindly provided by C. Carlberg. Sequences of
oligonucleotides used for site-directed mutagenesis are listed in Table 2.
To generate a vector expressing a fusion protein with the C-terminus of
RORα isoforms fused to the N-terminus of EGFP, the stop codons of the RORα
isoforms were replaced by site-directed mutagenesis to sequences coding for
alanine. cDNAs encoding the isoforms RORα1–3 were released with KpnI and
BamHI and inserted into pEGFP-N1 at these sites. The RORα4-cDNAwas cut
with EcoRI and BamHI and inserted into pEGFP-N1 at these sites. The resulting
constructs were denoted as RORα1/EGFP, RORα2/EGFP, RORα3/EGFP, and
RORα4/EGFP, respectively. In the resulting fusion proteins, the C-terminus of
RORα is fused to the N-terminus of EGFP through a GDPPVAT linker sequence.
To generate a vector expressing a fusion protein where the N-terminus of
RORα4 is linked to the C-terminus of EGFP, pSG5-RORα4 was digested with
HindIII and EcoRI. The released RORα4-cDNA fragment was inserted into
pEGFP-C2 at these sites. A stop codon in the linker region between EGFP and
receptor at position −1 of RORα4 was replaced by site-directed mutagenesis to a
sequence coding for alanine. The resulting plasmidwas denoted as EGFP/RORα4.
In the fusion protein, EGFP is linked to RORα4 through a SPHRAA linker.
Sequences coding for the A/B domains of the RORα isoforms were
generated by PCR using oligonucleotides inserting KpnI and BamHI sites and
the pCMX- or pSG5-expression vectors as templates. Fragments were inserted
into the KpnI and BamHI sites of pEGFP-C2 resulting in the expression vectors
EGFP/RORα1-A/B (aa 1–72), EGFP/RORα2-A/B (aa 1–105), EGFP/RORα3-
A/B (aa 1–97), and EGFP/RORα4-A/B (aa 1–17). The isoform-specific A/B
region of RORα4 was deleted from RORα4/EGFP by site-directed mutagenesis
resulting in the construct RORα-ΔA/B/EGFP.
To generate a RORα4 truncation mutant that lacks the C-terminal α-helix (aa
448–468), a stop codon was inserted by site-directed mutagenesis with the
Fig. 1. RT-PCR analysis of RORα isoform expression in different human cell
lines. Total RNA of the indicated cell lines was extracted, cDNA was
synthesized with oligo-d(T) priming and RT-PCR analysis of RORα isoforms
and β-actin was performed as described in Materials and methods.
Table 2
Oligonucleotide pairs used for construction of EGFP chimeras
Construct Sequence (5′→3′)
EGFP/RORα1-A/B GGGGT ACCGC ATGGA GTCAG
CTCTG GCAGC
CGGGATCCCT GGAAT AATTT CAATT
TGAGATGTAT GTGTC TT
EGFP/RORα2-A/B GGGGT ACCGC ATGAATGAGG GGGCC
CCAGG
CGGGATCCCT GGAAT AATTT CAATT
TGAGC ATTCATGTAT
EGFP/RORα3-A/B GGGGT ACCGC ATGAATGAGG GGGCC
CCAGG
CGGGATCCCT GGAAT AATTT CAATT
TGAGC TTTTC TCAAT
EGFP/RORα4-A/B GGGGT ACCAA ATGAT GTATT TTGTG ATCGC
AGAGA
CGGGATCCAT GGAAT AATTT CAATT TGAGC
TTTCATCT
RORα4-ΔA/B/EGFP CCGCA CCGCG ATTAA ATGCA AATTG AAATT
ATTC
GAATA ATTTC AATTT GCATT TAAGC GCGGT
GCGG
EGFP/RORα4-Δh12 CCAGA CATTG TGCGA CTTCATTAAC CTCCA
TTATA CAAGG AG
CTCCT TGTAT AATGG AGGTT AATGA
AGTCG CACAATGTCT GG
Table 3
Cellular localization of different RORα proteins
Construct Cell line
HeLa 293 HEK MCF-7 SH-SY5Y
RORα1/EGFP N N N N
RORα2/EGFP N N+C+M N+C N
RORα3/EGFP N N+C+M N+C N
RORα4/EGFP N N+M N N
EGFP/RORα4 N – – –
EGFP/RORα1-A/B N+C N+C – –
EGFP/RORα2-A/B C C – –
EGFP/RORα3-A/B C C – –
EGFP/RORα4-A/B C C – –
RORα-ΔA/B/EGFP N N – –
EGFP/RORα4-Δh12 – N – –
The localization is given as N—nuclear, C—cytoplasmic, and M—membrane
associated.
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construct was termed EGFP/RORα4-Δh12.
All constructs were confirmed by sequencing. A scheme of the generated
fusion proteins is given in Fig. 4A.
2.4. Analysis of intracellular distribution of EGFP fusion proteins
To determine the intracellular distribution of the different EGFP-RORα receptor
constructs, cells were grown on glass cover slips. For seeding of SH-SY5Y cells,
cover slips were coated with gelatin. Cells were transiently transfected by calcium
phosphate transfection [42] and fixed or lysed 17 h after transfection. In experiments
were NR ligands should be eliminated from the medium, cells were washed with
PBS after transfection and covered with DMEM that was supplemented with 10%
charcoal-stripped and silica-treated FCS. Cholesterol depletion was carried out for
6 hwith 10mM2-hydroxypropyl-β-cyclodextrin and 5μMcerivastatin. Transfected
cells growing on glass cover slips were rinsed with PBS, fixed for 10 min with ice-
cold methanol, and washed 3 times with PBS. Cover slips were embedded on slides
inmounting solution (50%glycerol in PBS) and sealedwith nail polish. Imageswere
taken by confocal laser scanmicroscopy (CLSM;Leitz DM-IRB; 488 nm, TCS4D).
For costaining of the nucleus, cells were stained with TO-PRO-3 iodide (Molecular
Probes). 24 h after transfection cells were fixed with 4% paraformaldehyde in PBS
for 10 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min and stained for
20 min with 1 mM TO-PRO-3 iodide in PBS with 1% BSA.
2.5. Western blot analysis
To obtain whole cell lysates, cells were seeded in 100 mm dishes containing a
glass cover slip for the control of transfection efficiency, transfected as described
above and harvested at 80–90% confluency. Cells were washed with PBS,
resuspended in ice-cold lysis buffer (50 mM Tris–HCl, pH=7.4, 150 mM NaCl,
10% glycerol, 2 mM EDTA, 2 mM EGTA, 40 mM β-glycerophosphate, 50 mM
NaF, 10 mM sodium pyruvate) and disrupted by drawing them 10 times through a
narrow-gauge syringe. Debris was removed by centrifugation, protein amount was
estimated according to Bradford. SDS-PAGE was carried out with 50 μg protein
per lane as described by Laemmli [43]. PBS with 0.05% Tween-20 and 5% dry
milk powder was used for blocking and antibody incubations. For the investigation
of full-length expression of EGFP-tagged RORα fusion proteins, both primary
(mouse-anti-GFP, Sigma) and secondary antibodies (goat-anti-mouse-AP, Sigma)were diluted at 1:5,000.Membranes were incubated in primary antibody for 3 h, in
secondary antibody for 1 h. After antibody incubation they were washed 3 times
with PBS/0.05% Tween-20. Detection was carried out with nitroblue tetrazolium
and 5-bromo-4-chloro-indolyl phosphate.
2.6. Reporter gene analysis
The reporter gene plasmid ROREα21-TKLUC, containing one copy of the
RORα2 response element (ATAACTAGGTCA),was kindly provided byV.Giguère
[28]. Two further copies of the same response element were inserted into the SalI and
HindIII sites resulting in the construct ROREα23-TKLUC. 40,000 HeLa or 100,000
293 HEK cells were seeded in 24-well plates using DMEMwithout phenol red, and
the following day the cells were cotransfected with 400 ng reporter gene plasmid
ROREα23-TKLUC and 40 ng expression vector for the EGFP-RORα fusion protein
by standard calciumphosphatemethod [42]. Cells were incubatedwith the precipitate
for 16 h beforemediumwas replaced. 24 h after transfection, cells were harvested and
processed for luminescence measuring using the Steady-Glo-kit (Promega) in a
Microlumat Plus LB96V (EG&G Berthold) luminometer. Transfection efficiency
was normalized by cotransfection of 20 ng pCMV-SEAP to determine the secreted
placental alkaline phosphatase activity usingPhospha-Light™-kit (Tropix). Induction
is related to cotransfection with the corresponding empty vector, pEGFP-N1 or
pEGFP-C2, given as mean+S.E. of three experiments, each performed in triplicate.
3. Results
3.1. RORα isoforms are differentially expressed in human cell lines
The endogenous RNA expression of RORα isoforms in a
number of human cell lines was analyzed on a qualitative level
by RT-PCR analysis. Due to the very low expression level, at
present, data on cellular RORα protein expression cannot be
808 A. Aschrafi et al. / Biochimica et Biophysica Acta 1763 (2006) 805–814obtained. Thus, RNA expression as a prerequisite for protein
expression was analyzed. Amplification of β-actin transcripts
served as a control for RNA quality and cDNA synthesis. In
general, RORα is expressed at a low level in the tested cell lines,Fig. 2. Functionality of RORα4 tagged with EGFP. (A–D) Subcellular distribution of
HeLa or 293 HEK cells were transiently transfected with the indicated expression vecto
(B) RORα4/EGFP in HeLa; (C) EGFP/RORα4 in HeLa; (D) RORα4/EGFP in 293 HE
sections of the indicated boxeswith (1) EGFP in green; (2) TO-PRO-3 in red; and (3) ove
columns) were transiently transfected with ROREα23-TKLUC reporter gene construct a
reporter gene activity was measured. Induction is related to transfection with the corr
experiments each performed in triplicate. (For interpretation of the references to colousince detection of RORα transcripts required PCR with at least
30 amplification cycles. As shown in Fig. 1, the most prominent
isoform was RORα1 as it was detected in a wide range of cell
lines, reflecting a nearly ubiquitous tissue distribution. RORα4EGFP fusion proteins (green) and costaining of the nuclei with TO-PRO-3 (red).
rs and images taken by CLSM. The bar represents 10 μm. (A) pEGFP-C2 in HeLa;
K. For each construct panel (1) shows an overview, panels (2–4) show magnified
rlay. (E) Transactivation byRORα. HeLa (black columns) or 293HEKcells (white
nd the indicated expression vector. Cells were harvested 24 h after transfection and
esponding empty vector pEGFP-N1 or pEGFP-C2, given as mean+S.E. of three
r in this figure legend, the reader is referred to the web version of this arcticle.)
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addition, its expression seems to be more tightly regulated, as for
instance the two Burkitt's lymphoma derived cell lines BL-41
and RAJI show different RORα4 expression patterns. In line
with the very restricted expression of RORα2 and RORα3,
transcripts of these isoforms were not detected in any of the
tested cell lines with the exception of low levels of RORα2 in
U266 cells (Fig. 1).
To investigate the subcellular localization of RORα we
chose four different adherent cell lines with different endoge-
nous RORα expression patterns—HeLa, expressing low levels
of RORα1 isoform; 293 HEK and MCF-7, expressing both
RORα1 and RORα4; and SH-SY5Y, expressing RORα1 and
low levels of RORα4 (Fig. 1).
3.2. EGFP is a functional tag to investigate subcellular RORα
distribution
To analyze subcellular distribution of the four RORα isoforms,
cDNAs encoding chimerical RORα proteins fused to EGFP were
constructed. These constructswere transiently transfected into four
different cell lines. In all experiments the transfection efficiencyFig. 3. Subcellular distribution of RORα isoforms in different cell lines. Cells were t
CLSM. The bar, given for each cell line in panel A, represents 10 μm. Expression of (
(1) HeLa; (2) 293 HEK; (3) MCF-7; (4) SH-SY5Y cells is shown.was in the range of 20–50%. All data concerning the subcellular
distribution of EGFP-tagged proteins are summarized in Table 3.
We tested whether RORα affects the subcellular distribution of
EGFP and if addition of EGFP impairs the functionality of
RORα4. The addition of RORα to the green fluorescent protein
changed the subcellular distribution of EGFP, which alone was
uniformly distributed throughout cells of all lines used in this study
(data shown forHeLa cells in Fig. 2A). N-terminal fusion of EGFP
to the RORα4 induced redistribution, with a green fluorescence
clearly restricted to the nucleus (Fig. 2B). As shown in Fig. 2A, the
green fluorescence of the EGFP-RORα4 chimera clearly colo-
calizeswith the nuclear staining (panels 2, 3 and 4). To determine if
the addition site might influence the subcellular localization, a
second vector containing C-terminally EGFP-tagged RORα4 was
constructed and transiently transfected into HeLa cells. Both
chimeras displayed identical fluorescence distribution, indicating
that the fusion site (N- or C-terminal) does not alter the subcellular
distribution of RORα4 (Fig. 2C).
To verify that the addition of EGFP to RORα4 does not
influence its transcriptional activity, a luciferase reporter gene assay
was performed in HeLa and 293 HEK cells. Cotransfection of the
expression vector for the RORα/EGFP fusion protein with aransiently transfected with the indicated expression vectors and images taken by
A) RORα1/EGFP; (B) RORα2/EGFP; (C) RORα3/EGFP; (D) RORα4/EGFP in
810 A. Aschrafi et al. / Biochimica et Biophysica Acta 1763 (2006) 805–814reporter gene plasmid containing three RORα response elements
upstream of the TK promoter and luciferase as reporter gene
revealed that EGFP-RORα4 is able to activate transcription (Fig.
2D) with an efficiency comparable to untagged RORα4 (12.8-
fold). The transactivation potential is not cell line-dependent. The
EGFP fusion site (N- or C-terminal) did not significantly influence
the transactivation potential of RORα4.
Having shown the functionality of the EGFP-tag in our system,
we used EGFP-tagged RORα proteins to characterize the sub-
cellular distribution of the fourRORα isoforms in different cell lines.
3.3. Subcellular localization of RORα is cell line-dependent
and isoform-specific
As shown in Fig. 3, the subcellular distribution of transiently
expressed EGFP-RORα fusion proteins revealed both cell line-Fig. 4. Characterization of the RORα-EGFP fusion proteins. (A) Structure of the
transiently transfected with the indicated expression vectors and harvested after 17
anti-GFP antibody. Bands of the molecular weight marker are indicated in lane M
numbered as in (A) and the expected size (in kDa) is given in brackets. (C) Repo
columns) were transiently transfected with RORα23-TKLUC reporter gene construc
24 h after transfection. Induction (black and dark grey columns) is related to transf
1–4) or pEGFP-C2 (construct 5), activity of mutant constructs 10 and 11 is given in
are given as mean+S.E. of three experiments done in triplicate.dependency aswell as isoform-specificity (see also Table 3). Only
GFP-tagged RORα1 was completely restricted to the nuclear
compartment in all four tested cell lines (Fig. 3A). GFP-tagged
RORα2 and RORα3 were completely nuclear in HeLa and SH-
SY5Y cells, but showed a lower restriction to this compartment
when expressed in 293 HEK andMCF-7 cells (Fig. 3B, C). GFP-
tagged RORα4 was mostly located in the nucleus (Fig. 3D).
3.4. Expression of different EGFP-RORα fusion proteins
To further address the isoform-specific localization we were
interested in the impact of different protein domains on the sub-
cellular distribution of RORα. Therefore, a series of EGFP-tagged
mutated RORα proteins was investigated (Fig. 4A). The integrity
of all chimeric proteins was checked by immunoblotting with an
anti-GFP antibody. All proteins were detected at the expectedRORα-EGFP fusion proteins. (B) Immunoblotting analysis. HeLa cells were
h. Cell lysates were analyzed by SDS-PAGE, blotting and detection with an
. Lysate from untransfected cells was used as control (lane C). Constructs are
rter gene analysis. HeLa (black and white columns) or 293 HEK cells (grey
t and the appropriate expression vector. Reporter gene activities were measured
ection with the corresponding empty expression vector pEGFP-N1 (constructs
% of the wild type RORα4 construct (white and light grey columns). All data
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were found (Fig. 4B). Therefore we can exclude the possibility,
that the observed fluorescence reflects degradation products of
these proteins. Furthermore, the transactivation potential of all
proteins still containing a DNA binding domain was determined
by reporter gene assaywithin two cell lines.We could show that all
four EGFP-tagged isoforms are active in the reporter gene assay
(Fig. 4C). Our results on the transactivation potential of the iso-
forms correspond with findings by Giguère et al. [28], where
RORα2 is much less active on the RORE used here compared to
RORα1. The transactivation potential does not significantly differ
between HeLa and 293 HEK cells. Only RORα1 showed a higher
transactivation potential in HeLa cells as in 293 HEK cells. Dif-
ferences in transcriptional activity between the four isoforms can
only be mediated by their different A/B domains. Interestingly, the
A/B domain of RORα4, being the shortest of the four A/B do-
mains, does not contribute to RORα4 transactivation, since the
truncated RORα4 protein missing this domain displays 110–
120% of the RORα4 activity (Fig. 4C, construct 10). The
truncated RORα4 protein missing helix 12 did not show any
transactivation potential (Fig. 4C, construct 11). Thiswas expected
since helix 12 is known to contain a glutamic acid residuewhich is
essential for the transcriptional activity by the recruitment of
coactivators [44].
3.5. The A/B domains of RORα2, 3, and 4 mediate cytoplasmic
localization
Differences in the subcellular localization of the four RORα
isoforms should be conferred by their N-terminal A/B domains,
since the isoforms differ only in these domains. To investigate
the role of the A/B domains, we expressed the four different A/B
domains as well as the common part of the RORα isoforms,
lacking the A/B domain and containing only DBD, hinge region
and LBD. As shown in Fig. 5, only the GFP-tagged A/B domain
of RORα1 was evenly distributed in the cells. (Fig. 5A1, B1),
whereas the other three A/B domains were exclusively found inFig. 5. Impact of the isoform specific A/B domains on the subcellular distribution of
and images taken by CLSM. The bar represents 10 μm. Expression of (1) EGFP/ROR
B; (5) RORα4-ΔA/B/EGFP in (A) HeLa and (B) 293 HEK cells is shown.the cytosol. With a molecular mass of less than 40 kDa, these
proteins are probably able to pass the nuclear pore complex by
simple diffusion. Therefore, the even distribution of the RORα1
A/B domain indicates that it should not contain any localization
signal, while the A/B domains of the other three isoforms should
possess a signal for nuclear export or cytoplasmic retention.
In contrast, the common part of the four isoforms, lacking an
A/B domain, was predominantly restricted to the cell nucleus
(Fig. 5A5, B5). These data indicate that the common part of the
RORα isoforms mediates nuclear localization.
The complete restriction of the untruncated RORα1 protein
to the nuclear compartment was most probably enabled by the
lack of a signal inducing cytosolic localization within its A/B
domain.
3.6. RORα can associate with the cell membrane
Besides a clear nuclear and cytosolic distribution, GFP-tagged
RORα isoforms 2, 3, and 4 expressed in 293 HEK cells were
additionally detected at cellular membranes (Fig. 6A1–3). In case
of RORα4 this membrane association was only observed in cells
that grew in medium supplemented with stripped FCS.
We found that deletion of the C-terminal part of RORα4
containing helix 12 resulted in the loss of ability of membrane
association. As shown in Fig. 6A4, the membrane association of
RORα4 found in 293 HEK cells was not detected in this trun-
cation mutant, which suggests that membrane association is
mediated by helix 12.
At cellular membranes RORα might gain direct access to its
putative ligand cholesterol which could regulate the functions of
the membrane associated receptor form. Therefore, we investi-
gated whether cholesterol depletion influences the subcellular
localization of RORα2, RORα3, and RORα4. To deplete choles-
terol from the cell, medium supplemented with charcoal-stripped,
delipidated FCS was used. Free cholesterol was depleted using 2-
hydroxypropyl-β-cyclodextrin, intracellular cholesterol synthesis
was inhibited with cerivastatin for 6 h. Under these conditions,RORα. Cells were transiently transfected with the indicated expression vectors
α1-A/B; (2) EGFP/RORα2-A/B; (3) EGFP/RORα3-A/B; (4) EGFP/RORα4-A/
Fig. 6. Plasma membrane association of RORα in 293 HEK cells. Cells were transiently transfected with the indicated expression vectors and images taken by CLSM.
The bar represents 10 μm in panel A. Panel B represents a magnified section of the indicated box in panel A. As indicated, cells were cultured in stripped medium after
transfection. A more detailed view of RORα2/EGFP localization is given in panels (C) and (D). In (D) cells were cholesterol depleted after transfection for 6 h. Panel
(1) shows an overview, panels (2–4) show magnified sections of the indicated boxes with (2) EGFP in green; (3) TO-PRO-3 in red; and (4) overlay. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 6C and D).
4. Discussion
RORα displays an isoform-specific expression in different
tissues, due to different promoter usage and alternative splicing.
Transcripts ofRORα4were found in awide range of human organs
and tissues including brain, heart, lung, and skinwith highest levels
detected in peripheral blood leukocytes [29]. The expression of
RORα1 is likewise ubiquitouswith differences in expression levels
compared to RORα4. For instance, in mouse liver cells, RORα4
expression is predominant compared to RORα1 [45]. Within
human vascular cells, the expression of RORα1 is higher in endo-thelial cells, while aortic smooth muscle cells and normal arteries
express higher levels of RORα4 [46]. As described for different
human tissues, RORα1 and RORα4 were found to be widely
expressed in human cell lines with differing expression levels.
In contrast to RORα1 and 4, the expression of the two human
isoforms RORα2 and RORα3 is very restricted. RORα3 could
only be detected in the tissue where it was cloned from, in human
testis [28]. In addition to the expression in human testis, RORα2
was recently found in cells of the immune system [32]. In line with
these data, we could not detect RORα3 in any of the tested cell
lines, while RORα2 was found in the B cell line U266, corres-
ponding with its detection in CD19+ B cells [32]. Although
RORα2 was also found in human T cells, none of the tested T cell
lines showed an expression of this isoform. As described for
813A. Aschrafi et al. / Biochimica et Biophysica Acta 1763 (2006) 805–814different human tissues, RORα1 and RORα4 were found to be
widely expressed in human cell lines with differing expression
levels.
Furthermore, we could show in this study that the RORα
isoforms are not only differentially expressed but they also differ in
their subcellular localization representing an additionalmechanism
for the regulation of RORα transcriptional activity. Many nuclear
receptors are known to shuttle between the cytosol and the nucleus
[10]. The regulation of their subcellular distribution depends on
nuclear localization signals and nuclear export signals located in
different receptor domains.
Nuclear translocation is due to the presence of NLS, short
sequences rich in basic amino acids, often found at the junction of
DBD and hinge region [47]. For many ligand-activated receptors,
an additional NLS in the LBDwas described, which functions in a
ligand-dependent manner [15]. However, the sequence of these
ligand-dependent NLS still remains unknown. For the orphan
nuclear receptor Rev-erbα, closely related to RORα, an unusual
NLS was identified recently within the DNA binding domain
[47]. This NLS is based on two basic residues not present in
RORα excluding the presence of this signal in theDBDofRORα.
We could show that the common part of the four isoforms com-
prising the DBD, the hinge region and the LBD mediates nuclear
localization.
Nuclear export signals are often sequences rich in leucine
residues [48]. However, for diverse nuclear receptors missing such
a leucine-rich NES an alternative nuclear export signal within the
DBD was identified [20]. It encompasses two conserved phenyl-
alanine residues located between the two zinc fingers. Such a NES
might also be present in RORα, since its DBD was found to be
exclusively located in the cytosol of COS-1 cells [47] and double
mutation of these two residues resulted in a complete restriction of
the protein to the nucleus of 293 HEK and HeLa cells (data not
shown). Furthermore, we identified a signal mediating cytoplasmic
localization in the A/B domains of the RORα isoforms 2, 3, and 4,
whereas the A/B domain of RORα1 does not affect cellular local-
ization. Thereby, RORα is the first nuclear receptor for which an
isoform-specific localization is described, that results from differ-
ential localization signals within the isoform-specific A/B domains.
Whether the strict cytoplasmic localization mediated by the A/B
domain is due to nuclear export or cytoplasmic retention remains to
be elucidated. Formany nuclear receptors, cytoplasmic localization
was shown to be dependent on a nuclear export signal [17,20].
However, nuclear export can also occur without this NES [49,50].
Furthermore, we could identify RORα as one of the nuclear
receptors that can also associate to cellular membranes. An asso-
ciation with the plasma membrane was recently described for the
vitaminD receptor [24]. For the estrogen receptor it was shown that
the membrane-associated form has rapid non-genomic effects—it
is involved in signaling cascades from the cellular membrane
[21,22]. We could show that the C-terminal helix 12, known to be
essential for the interaction of nuclear receptors with coactivator
proteins [49], is involved in the membrane association of RORα4.
The missing membrane association of RORα1 might be explained
by the lack of cytoplasmic localization, theNLS in the hinge region/
LBD probably prevents its cytosolic localization and subsequently
its membrane association. The functional role of the observedmembrane association remains to be elucidated. We hypothesized
that at cellular membranes RORα might gain direct access to its
putative ligand cholesterolwhich could regulate the functions of the
membrane associated receptor form. However, cholesterol deple-
tion of 293 HEK cells did not alter RORα localization.
Altogether, our results and previous data in the literature
suggest that RORα activity is regulated atmultiple levels. Usage of
different promoters and alternative splicing results in differential
isoform-specific tissue expression. Here, we could show that the
isoform-specific A/B domains mediate different access of RORα
to the nucleus resulting in regulation of transcriptional transactiva-
tion of this constitutively active nuclear receptor. Thus, in addition
to their different DNA binding properties, cellular distribution
seems also to contribute to the differences between the isoforms in
receptor function.
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